title: Fibronectin (FN) decreases glomerular lesions and synthesis of tumour necrosis factor-alpha (TNF-alpha), platelet-activating factor (PAF) and FN in proliferative glomerulonephritis.
abstract: We have studied the effect of therapy with plasma FN on glomerular synthesis of PAF, TNF-alpha and FN, in experimental proliferative glomerulonephritis. Glomerular PAF, TNF-alpha and FN production were increased in rats with nephritis. Peak glomerular PAF production preceded, while peak glomerular TNF-alpha bioactivity coincided with maximal proteinuria. Rats treated with FN (5 mg/kg per 48 h) for 15 days had less proteinuria, glomerular and interstitial cell infiltration and glomerular PAF, TNF-alpha and FN synthesis than non-treated rats. In order to characterize further the mechanisms of action of FN, healthy rats were injected with either FN or saline. Peripheral blood mononuclear cells and neutrophils from healthy rats injected with FN secreted less TNF-alpha and PAF, respectively, than those obtained from saline-treated rats. Our data suggest that the beneficial effect of FN may be related to decreased number of glomerular leucocytes and decreased synthesis of inflammatory mediators and extracellular matrix.
authors.affiliation: Fundación Jiménez Díaz, Universidad Autónoma, Madrid, Spain.
authors.forename: A
authors.initials: A
authors.lastname: Ortíz
authors.forename: J
authors.initials: J
authors.lastname: Alonso
authors.forename: M
authors.initials: M
authors.lastname: Gómez-Chiarri
authors.forename: J L
authors.initials: JL
authors.lastname: Lerma
authors.forename: D
authors.initials: D
authors.lastname: Seron
authors.forename: E
authors.initials: E
authors.lastname: Condom
authors.forename: E
authors.initials: E
authors.lastname: González
authors.forename: J
authors.initials: J
authors.lastname: Egido
mesh_terms: D000818:Animals; D005109:Extracellular Matrix / Q000187:drug effects / Q000378:metabolism; D005353:Fibronectins / Q000096:biosynthesis* / Q000494:pharmacology*; D005920:Glomerular Mesangium / Q000187:drug effects / Q000378:metabolism; D015432:Glomerulonephritis, Membranoproliferative / Q000188:drug therapy* / Q000378:metabolism*; D007668:Kidney / Q000166:cytology / Q000378:metabolism; D007963:Leukocytes, Mononuclear / Q000378:metabolism; D008297:Male; D009504:Neutrophils / Q000378:metabolism; D010972:Platelet Activating Factor / Q000096:biosynthesis*; D051381:Rats; D017208:Rats, Wistar; D014409:Tumor Necrosis Factor-alpha / Q000096:biosynthesis*
chemical_list: D005353:Fibronectins; D010972:Platelet Activating Factor; D014409:Tumor Necrosis Factor-alpha